Article

CIBA Vision introduces new corporate identity

CIBA Vision has announced a new corporate identity, including a corporate logo and purpose statement:

Atlanta-CIBA Vision has announced a new corporate identity, including a corporate logo and purpose statement: "Shared passion for healthy vision and better life."

"We are proud of our history and the progress we have made and yet remain committed to continuously raising our game to ensure that we not only satisfy, but truly partner with, eye-care professionals (ECPs) to delight consumers with innovative products," said Richard E. Weisbarth, OD, FAAO, vice president, global head, professional development and partnerships, CIBA Vision.

CIBA Vision will phase in the new logo on product packaging and other materials throughout this year, with full transition to the new logo on its product line expected by the end of next year.

To better partner with and support ECPs in bringing the benefits that these new products offer to their patients, CIBA Vision also is increasing its investment in programs to educate professionals on enhancing the patient experience and improving the business performance of their practices.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.